BFLY Share Price Performance
US$4.47
4.47 (0.00%)
148.3% overvalued intrinsic discount
US$1.80
Fair Value
Price US$4.47
Gil263 US$1.80
AnalystConsensusTarget US$5.56
AnalystLowTarget US$5.25
Fair ValueUS$1.80
Share Pricen/a
Seeking Alpha • May 03
Butterfly Network, Inc. Stock Price
- 4 Narratives written by author
- 2 Comments on narratives written by author
- 46 Fair Values set on narratives written by author
BFLY Community Narratives
GI
Fair Value
·Fair Value US$1.8 148.3% overvalued intrinsic discount
A buy recommendation
2users have liked this narrative
1users have commented on this narrative
3users have followed this narrative
AN
Fair Value
·Fair Value US$5.56 19.6% undervalued intrinsic discount
AI And Portable Imaging Will Advance Global Healthcare Diagnostics
1users have liked this narrative
1users have commented on this narrative
29users have followed this narrative
AN
Fair Value
·Fair Value US$5.25 14.9% undervalued intrinsic discount
Delays And Burn Will Hinder Progress While Telehealth Will Help
0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
A buy recommendation
In a nut shell, I saw Butterfly Network as a medical break through and bought a few hundred shares at a $1.55/shr. and the following news confirmed my reasoning of buying; On November 17, 2025, Butterfly Network’s subsidiary signed a five-year co-development and licensing agreement with Midjourney for exclusive access to its semiconductor-based ultrasound technology, securing a US$15 million upfront payment, US$10 million annual license fees, and further milestone and revenue-sharing potential.Read more
AI Integration And Telemedicine Will Expand Portable Ultrasound Markets
Key Takeaways Butterfly's advancements in AI-driven imaging and ecosystem development position it for accelerating mass adoption, top-line growth, and margin expansion within enterprise healthcare. Early-mover advantages in global deployment and home care applications could drive new, recurring, and higher-quality revenue streams as healthcare shifts to more decentralized models.Read more
AN
US$6
25.5% undervalued intrinsic discount
Fair Value
Profit Margin
12.79%
Future PE
100.33x
Price in 2029
US$7.5
Delays And Burn Will Hinder Progress While Telehealth Will Help
Key Takeaways Delays in closing key enterprise deals, provider hesitancy, and global funding uncertainty may hinder Butterfly Network's revenue growth and widespread adoption. High R&D spending and market commoditization risks could limit margin expansion and delay sustainable profitability despite growing commercial interest and an expanding platform ecosystem.Read more
AN
US$5.25
14.9% undervalued intrinsic discount
Fair Value
Profit Margin
12.7%
Future PE
91.99x
Price in 2029
US$6.56
AI And Portable Imaging Will Advance Global Healthcare Diagnostics
Key Takeaways Expanding enterprise deals, clinical AI apps, and HomeCare pilots position Butterfly for growth in recurring digital revenue aligned with decentralized, accessible healthcare trends. Product and software innovations, cost reductions, and successful commercialization efforts support higher adoption, improved gross margins, and pave the way to scalable profitability.Read more
AN
US$5.56
19.6% undervalued intrinsic discount
Fair Value
Profit Margin
13.36%
Future PE
94.12x
Price in 2029
US$6.93
Trending Discussion
Recently Updated Narratives
GI
A buy recommendation
Fair Value: US$1.8 148.3% overvalued intrinsic discount
3 fair values setusers have set this as their fair value
1 commentusers have commented on this narrative
0 likesusers have liked this narrative
AN
BFLY: Embedded Platform Shift And AI Tools Will Support Future Upside
Fair Value: US$6 25.5% undervalued intrinsic discount
2 fair values setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
BFLY: Embedded Platform And AI Tools Will Reshape Future Earnings Profile
Fair Value: US$5.25 14.9% undervalued intrinsic discount
1 fair value setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
Snowflake Analysis
Butterfly Network, Inc. Key Details
About BFLY
- Founded
- 2011
- Employees
- 220
- CEO
- WebsiteView website
Butterfly Network, Inc. develops, manufactures, and commercializes ultrasound imaging solutions in the United States and internationally. The company offers Butterfly iQ+ and iQ3 ultrasound devices that can perform whole-body imaging on a single handheld probe integrated with the clinical workflow, and accessible on a user’s smartphone, tablet, and almost any hospital computer system; Butterfly Move, merging the mobility of a handheld with the stability of a full cart system; and iQ+ Bladder, a specialty product for bladder scanning market. It also provides Compass AI which offers one system to connect every device, workflow, and department; ScanLab, an AI-powered educational platform that provides written walkthroughs and reference imagery to guide real-time educational scanning; and Butterfly iQ+/iQ3 Vet, a third generation handheld ultrasound system. It sells and markets its products through a direct sales force, distributors, and e-commerce channels. Butterfly Network, Inc. was founded in 2011 and is headquartered in Burlington, Massachusetts.
